Skip to content

Integrated Cardiovascular Risk Evaluation and Personalized Management for Middle-Aged and Older Adults

Integrated Cardiovascular Risk Evaluation and Personalized Management for Middle-Aged and Older Adults

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500110785
Enrollment
Unknown
Registered
2025-10-21
Start date
2022-07-15
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Risk Factors for Caridiovascular Diseases

Interventions

Precision Cardiovascular Risk Management Group:Based on baseline information and the latest clinical guidelines, cardiovascular experts set individualized control targets for blood pressure, blood lip
Traditional chronic disease Management group:Routine chronic disease management at community health centers

Sponsors

Fuwai Hospital, Chinese Academy of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age over 40, gender not limited; 2. Source: Residents from the communities under the jurisdiction of the community health service center who are willing to participate in this project and can receive basic diagnosis and treatment for hypertension, dyslipidemia and diabetes at designated medical institutions during the project implementation period. 3. Those who belong to the medium or high-risk groups based on the Chinese-PAR model of the Chinese cardiovascular risk assessment tool, or have been diagnosed with atherosclerotic cardiovascular disease Patients with disease,ASCVD (including ischemic stroke, coronary atherosclerotic heart disease, and peripheral vascular disease). 4. Those who have a clear diagnosis of at least one of the following: hypertension, dyslipidemia, or diabetes, and at least one of them fails to meet the standard. The specific diagnostic criteria are as follows: Hypertension: Any one of the following three conditions can be diagnosed as hypertension: A. Without the use of antihypertensive drugs, if the systolic blood pressure is 140 mmHg and/or the diastolic blood pressure is 90 mmHg or above in three measurements on different days, it can be diagnosed as hypertension. B. The patient has a previous history of hypertension; C. Currently taking antihypertensive drugs. Type 2 diabetes: If there are symptoms of metabolic disorders (including polydipsia, polyuria, polyphagia and unexplained weight loss), fasting blood glucose >=7.0mmol/L, or a clear history of diabetes, or if one is currently taking hypoglycemic drugs. Dyslipidemia: LDL-C in the general population is >=4.1 mmol/L, or the LDL-C control target is not reached according to the ASCVD risk stratification. Blood pressure not up to standard: systolic blood pressure >=140mmHg and/or diastolic blood pressure >=90mmHg; LDL-C not meeting the standard: The target value of LDL-C is not reached according to the ASCVD risk stratification. Blood glucose not reaching the standard: FPG>=7.0mmol/L. 5. I or with the help of my family members can use regular applications such as smart phone apps and information reception and reading.

Exclusion criteria

Exclusion criteria: 1.Patients with cardiovascular diseases (such as myocardial infarction, stroke, etc.) that have occurred within three months; 2. Patients with malignant tumors or other serious systemic diseases; 3. Those who are unable to take care of themselves; 4. Inability to cooperate with health management and follow-up for various reasons.

Design outcomes

Primary

MeasureTime frame
Hypertension (systolic and diastolic blood pressure), dyslipidemia (low-density lipoprotein cholesterol), and diabetes (fasting blood glucose) compliance rates;Changes in blood pressure, blood lipid levels, and blood sugar levels (both between groups and within groups);

Secondary

MeasureTime frame
China Cardiovascular Risk Assessment Tool - China-PAR Model Risk Score;Major adverse cardiovascular events (all cardiovascular deaths, myocardial infarction, hospitalizations due to unstable angina pectoris, stroke, transient ischemic attack (TIA), hospitalizations due to heart failure events, coronary artery revascularization treatment, peripheral vascular interventional procedures), all-cause death;

Countries

China

Contacts

Public ContactAimin Dang

Fuwai Hospital, Chinese Academy of Medical Sciences

amdangfw@163.com+86 10883982140

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 14, 2026